Introduction
Antiepileptic drugs (AEDs) are medications usually taken long-term to prevent the occurrence of seizures in epileptic patients. AEDs can also be used to prevent seizures in patients with meningitis or in the early period following either neurosurgery or traumatic brain injury. In addition, certainAEDs are used to terminate ongoing seizures, such as instatus epilepticus (SE) or prolonged febrile seizures [17]. The goals of AEDs are to reduce the number of seizures or to enhance the patient’s quality of life. Bromide was introduced as the first AED in 1857, but because of adverse effects, it is no longer in use [25]. Depending on the mechanism of action, currently prescribed AEDs are classified as those that enhance gamma aminobutyric acid (GABA)-mediated inhibitory neurotransmission, modulate voltage-gated ion channels, or reduce synaptic glutamate transmission [8]. However, although more than 40 AEDs have been developed, epilepsy is not controlled in 20-30% of patients with any of the currently approved AEDs [31]. Therefore, the identification of new drug targets involved in epileptogenesis and the control of seizure initiation and/or propagation are urgently required.
B-cell-specific Moloney murine leukemia virus integration site 1 (Bmi1) is a member of polycomb group (PcG) proteins and is a core component of polycomb repressive complex 1 (PRC1) [33]. Bmi1 is a constituent of the multimeric protein complex and is involved in regulating the cell cycle [36]. Initial studies have focused on the role of Bmi1 in tumorigenesis. For example, Bmi1 plays a crucial role in tumorigenesis by regulating the tumor suppressor proteins of p16Ink4a and p19Arf [23]. Bmi1 also regulates p53 stability by binding with the p53 complex, which leads to p53 inactivation [3]. Furthermore, Bmi1 is overexpressed in cancer cells such as those of prostate, breast, lung, ovarian, and bladder cancers [37,38].
Recent findings suggest that Bmi1 is involved in neuroprotection through, for example, its role in regulating mitochondrial function, reactive oxygen species (ROS) levels,and DNA damage processes [22]. In addition, Bmi1 is downregulated in aging brains and in brains with neurodegenerative diseases, such as Alzheimer’s disease [5]. Furthermore, Bmi1 might play an important role in the repair of DNA double-strand breaks [13]. Since these devastating events are common following epileptic seizures, including SE, and DNA double-strand breaks are the main inducer of neuronal death, Bmi1 could be an important therapeutic target against epilepsy.
In this study, we evaluated the role of Bmi1 in the pathogenesis of pilocarpine-induced SE in mice. We used a mouse model of SE with atropine and pilocarpine. The mice usedin this study are heterozygous knockout mice for Bmi1 since the homozygous knockout mice are lethal during development. This strain has reduced expression levels of Bmi1 in the whole brain. With this animal model, we investigated neuronal damage and epileptogenesis and evaluated Bmi1as a novel target against epilepsy
Materials and Methods
Animals
Male Bmi1+/-(Bka.Cg-PtprcbBmi1tm1IlwThy1a/J) mice were obtained from The Jackson Laboratory (BarHarbor, ME,USA) and crossed with wild-type females (C57BL/6). The genotypes of the pups were determined by polymerase chain reaction (PCR) analysis according to Jackson Laboratory guidelines. The specific primers used in this study were 5’-GAGAATCCAGCTGTCCAGTGT-3’ for common forward primer and 5’-TACCCTCCACACAGGACACA-3’ or 5’-GAACTTCAGGGTCAGCTTGC-3’ for wild type and mutant reverse primers, respectively. All mice were housed in standard temperature (22±1℃) and humidity (50% ±5%) conditions, with the light-controlled from 8:00 a.m. to 8:00 p.m.(12 hr interval), and they had ad libitum access to food and water. The facility for the Living Modified Organism(LMO) was approved by the Ministry of Science, ICT, and Future Planning (LML 15-537). The animal experimental protocol was approved by the University Institutional Animal Care and Use Committee (IACUC-2014-015).
Real-time quantitative PCR analysis
To determine the expression level of Bmi1 in the hippocampus, real-time quantitative PCR was performed. The RNA was extracted from the hippocampus using the Mini BEST Universal RNA Extraction kit (TaKaRa Dalian Biotechnology Co., Ltd. Dalian, China) according to the manufacturer's protocol. The RNA concentration was adusted with a NanoDrop spectrophotometer (MaestrogenInc., Las Vegas, NV). Real-time PCR amplification was performed using gene-specific primers and One-step SYBR® Prime Script™ RT-PCR Kit (TaKaRa Dalian Biotechnology Co., Ltd) with Bio-Rad CFX-96 thermocycler (Bio-Rad Laboratories Inc., Hercules, CA). Cycling conditions were as follows: 42℃ for 5 min, 95℃ for 10 sec, and 40 cycles. The primer sets were 5’-TGGCTCCAATGAAGACCGAG-3’ (forward) and 5’-TGCTGGGCATCGTAAGTACC-3’ (reverse) for Bmi1, or 5’-TACTGCCCTGGCTCCTAGCA-3’ (forward) and5’TGGACAGTGAGGCCAGGATAG-3’ (reverse) for β-actin.
Pilocarpine-induced status epilepticus in mice
Mice were administered with atropine (2 mg/kg, i.p.) and terbutaline hemisulfate salt (2 mg/kg, i.p.) and after 30 min they were injected with pilocarpine hydrochloride (295mg/kg, i.p.) dissolved in saline. Convulsive behaviors were closely monitored for approximately 6 hr. The stage of seizure was determined according to Racine’s scale: Stage 1,facial clonus; Stage 2, head nodding; Stage 3, forelimb clonus; Stage 4, rearing; and Stage 5, rearing and falling [27]. Animals that showed stage 5 generalized tonic-clonic seizures (rearing and falling) or higher were selected for further study
Tissue processing
Mice were anesthetized with 15% chloral hydrate and transcardially perfused with saline, followed by 4% paraformaldehyde in 0.1 M phosphate buffer solution (PBS, pH7.4). Brains were postfixed for 4 hr at 4℃ and then cryoprotected in a 30% sucrose solution (0.1 M PBS). The sequential coronal sections (30 µm) through the hippocampus(bregma -1.28 ~ -2.92 mm) were prepared using a freezing cryotome (SM2010R; Leica Biosystems, Germany).
Immunohistochemistry
For immunohistochemical labeling, sections were blocked with 10% normal goat serum in PBS, followed by overnight incubation (4℃) with rabbit polyclonal anti-Bmi1 antibodies(1:500; Santa Cruz, CA). Sections were then processed using the ABC staining method (Vector Laboratories, Burlingame,CA) and diaminobenzidine (DAB; Vector Laboratories) was used to visualize the signal.
Cresyl violet staining
Cell viability was evaluated using cresyl violet. The micewere euthanized at 3 days post SE, and the tissues were processed as described above. The sections were mounted on gelatin-coated slides. Sections were serially rehydrated in alcohol (100% to 70%) and tap water, then incubated in 0.1% cresyl violet solution (Sigma, St. Louis, MO, USA) for 20 min. After destaining with 95% ethanol containing 0.1% glacial acetic acid, the sections were dehydrated, dried, and mounted with Permount (Sigma, St. Louis, MO, USA). The severity of the neuronal damage in the hippocampus was evaluated by an examiner blinded to the study groups. The severity was semiquantitatively assessed according to the method described previously with minor modification [18]. Neuronal damage was measured on the following scale: no neuronal damage, grade 0; less than 20% neuronal damage, grade 1; 21 ~ 50% neuronal damage, grade 2; 51–100% neuronal damage, grade 3.
Neuronal toxicity assay
Hippocampi were isolated from postnatal day 1 mice and put into a 1.5 mL polyethylene tube. Hippocampi were dissociated with trypsin and isolated cells were seeded on a 24-well plate. Isolated hippocampi from one pup were not mixed with the tissue from another, and each tail was cut and genotyping was carried out to determine their genotype, as described above. The cells were maintained in Neurobasal media supplemented with 2% B27, 1% penicillin/streptomycin, and 0.25 mM glutamine (all culture media were from Gendepot, Katy, TX) for 10 days. N-methyl-D-aspartate (NMDA, 25 μM) was added to the culture for 1 hr, and the cell culture media was collected at 12 hr later for the measurement of lactate dehydrogenase (LDH) release as a measure of cell membrane integrity.
Behavioral assessment of spontaneous recurrent seizures
Spontaneous recurrent seizures were monitored at 1 or 2 months after SE induction. For this study, animal behavior was recorded for 10 hr per day for 1 week. Frequency and duration of spontaneous recurrent seizures were analyzed on the screen.
Timm’s staining
After the last monitoring for recurrent seizures, mice were euthanized, as previously described [20]. Mice were transcardially perfused with saline followed by sodium phosphate buffer containing 1.2% Na2S. Brains were postfixed for 2 days in 10% neutral-buffered paraformaldehyde (pH 7.4), then transferred to a 3% glutaraldehyde solution for 90 min, and finally cryoprotected in a 30% sucrose solution (0.1 M PBS). Sequential coronal sections (30 µm)through the whole hippocampus were prepared using acryotome. The sections were mounted on gelatin-coated slides and dried. After rehydration in a graded alcohol series, the sections were stained with a solution containing 30% gum arabic, 1.7% hydroquinone, and 0.085% silver nitrate in a citrate buffer. After dehydration, the sections were covered with Permount. The optical density of Timmstained axonal terminals in the dentate gyrus was measured using Photoshop® software.
Statistical analysis
Data are presented as mean ± SEM, and the significance was assessed using GraphPad Prism (version 3.0). Statistical significance was accepted when p<0.05
Results
Expression of Bmi1 following pilocarpine-induced status epilepticus
Pilocarpine-induced SE induces neuronal cell death inCA1 and hilus. On the other hand, granule cells in the dentate gyrus are resistant to SE and only minor cell damage is observed in the CA3 region. We examined the expression pattern of Bmi1 in the hippocampus of normal mice. The expression level of Bmi1 is quite low in the whole hippocampus (Fig. 1). However, robust expression of Bmi1 is observed in the pyramidal cell layer of the CA1 and CA3 region and dentate gyrus at 6 hr after SE. At 4 days after SE, Bmi1 expression was remained in the CA3 pyramidal cell layer, but not in the CA1 area. In addition, Bmi1 expression was also observed in the glial cells at 4 days post SE. These data suggest that Bmi1 may be involved in the hippocampal pathogenesis of SE. To test this hypothesis, we used Bmi1 knockout mice.
Fig. 1. Immunohistochemistry of Bmi1 in the hippocampus. Compared to control, Bmi1 expression is transiently increased in the CA1, CA3 and dentate gyrus at 6 hr post SE. At 4 days post SE, the expression level of Bmi1 is observed in the glial cells throughout the hippocampus.
Phenotypic verification of Bmi1 knockout mice
Male Bmi1+/- (Bka.Cg-Ptprcb Bmi1tm1Ilw Thy1a/J) mouse was crossed with female C57BL/6J wild type mice. Genomic DNA of pups was isolated from mouse tail tissue, and theDNA template was amplified using PCR. The mutant allele was confirmed as a heterozygous knockout in mice (Fig.2A). In this study, heterozygous knockout mice were used because mice homozygous for the Bmi1 knockout allele die before birth or soon after they are born (provider’s information, The Jackson Laboratory. Bar Harbor, ME). The expression level of Bmi1 mRNA in heterozygous knockout mice was reduced by more than 50% (Fig. 2B).
Fig. 2. Expression of Bmi1 mRNA in Bmi1 heterozygous mice. (A) Targeted allele was identified by PCR products ofDNA extracted from tails. (B) The expression level of Bmi1 mRNA in the hippocampus from each genotype. Data were represented as relative ratio to Bmi1+/+ (mean± SEM, n = 4 for each group). ** p<0.005 compared to control.
Neuronal cell death in the Bmi1 knockout mice following status epilepticus
SE was induced in Bmi1+/- mice and its wild type littermates, and 3 days later neuronal damage was examined with cresyl violet staining. First, there was no significant difference in seizure behavior (stage V seizure, SE, and mortality) between the two groups (Table 1). However, the percent of SE induction in Bmi1+/- mice was 10.44% higher than that in wild type littermates. At 3 days after SE, neuronal damage in the CA1 and hilus regions was induced in both groups, and there was no significant difference in cell death between the two groups (Fig. 3). Next, we tested neuronal vulnerability in cultured hippocampal neurons from Bmi1+/- pups and wild type littermates. In this experiment,there was no significant difference in NMDA-induced neuronal damage between the two groups (Fig. 4). These invivo and in vitro data indicate that reduced expression of Bmi1 does not affect neuronal damage in SE.
Table 1. Seizure behaviors following pilocarpine injection
SV: stage V, SE: status epilepticus
*Onset time of SV or SE seizure means time of stage V or SE seizure onset taken after pilocarpine injection.
Fig. 3. Neuronal damage in the hippocampus following pilocarpine-induced status epilepticus. (A) Representative images of cresylviolet stained-hippocampal sections. Neuronal damage is observed in the CA1, CA3 and the hilus. DG; dentate gyrus, Hil;hilus. (B) Semi-quantitative analysis of hippocampal damage indicates that there is no significant difference between Bmi1+/-mice and wild type littermates (n=5 for each group).
Fig. 4. NMDA-induced cytotoxicity in culture hippocampal neurons. Although neuronal damage increased by NMDA incubation, there was no significant difference between cultured neurons from Bmi1+/- pups and wild type littermates. Data were represented as mean ± SEM,(n=4 for each group
Epileptic behavior in Bmi1 knockout mice following status epilepticus
Pilocarpine-induced SE is a well-known animal model of epilepsy. In this study, we monitored the behavior of epilepsy and recurrent seizures in mice that showed SE. Although there was no significant difference, the frequency of recurrent seizure was lower in Bmi1+/- mice compared to the wild type littermates. On the other hand, the duration of recurrent seizure was similar between two groups (Table 2). SE induces mossy fiber outgrowth in the dentate gyrus,and it has been reported that mossy fiber outgrowth is involved in epileptogenesis. In our study, mossy fiber outgrowth was significantly increased in Bmi1+/- mice compared to wild type animals (Fig. 5)
Table 2. Frequency and duration of recurrent seizure
Fig. 5. Mossy fiber sprouting. (A) Representative images of mossy fiber sprouting from control or 2 months post SE. (B) Quantitative analysis of mossy fiber sprouting. Relative density from Bmi1+/- mice was significantly higher compared to that of wild type littermates. Data are represented as mean ± SEM. *p<0.05 and ***p<0.001 compared to control animals and ##p<0.01 compared to the epileptic wild type littermates (Bmi1+/+, 2 months post SE).
Discussion
Bmi1 is the core component of PRC1 and has been identified as a Myc cooperating oncogene in murine B- and T-cell lymphomas. Bmi1 has also been identified as an oncogene promoting carcinogenesis in cancers, including prostate,lung, ovarian, urinary bladder, and breast cancer, and lymphoma, mesothelioma, medulloblastoma, glioma, acute myeloid leukemia [16]. Likewise, Bmi1 inhibitors promoted cell cycle arrest in cervical cancer cell lines, induced a temporal decrease in ATP, and compromised the mitochondrial redoxbalance resulting in caspase-dependent apoptosis [10,21]. On the other hand, during development, Bmi1 plays an important role in primitive endoderm formation and the development of hematopoietic cells and the axial skeleton and cerebellum [7, 11, 19]. Combined, it is believed that Bmi1is an essential component for embryonic development andcell proliferation and survival.
Recently, the roles of Bmi1 in the central nervous system has been realized. For example, Bmi1 hemi-deficiency(Bmi1+/-) mice showed reduced median and maximal lifespans and showed impaired learning and memory ability at age 15 months [5,12]. In addition, tau levels increased in the cortex of 22-24 month-old Bmi1+/- mice [12]. In the eyes, cone photoreceptors and bipolar neurons are normally generated, but these undergo rapid degeneration in Bmi1-/-mice caused by Rip3-associated necroptosis [2]. Interestingly, there is increasing evidence showing that Bmi1 may be involved in neuroprotective effects in the central nervous system. First, Bmi1 transcription has been shown to be transiently increased in the CA3 region when focal-onset SE was induced by the stereotaxic microinjection of kainic acid into the amygdala. However, there was no significant difference in the CA1, which is the region most vulnerable to pilocarpine-induced SE [29]. Second, Bmi1 expression increased in the ischemic-preconditioned brain and knocking down Bmi1 with siRNA ablated the tolerance to oxygen-glucose deprivation in cultured cells and increased tissue infarction in animal models of strokes [34]. Third, increased expression of Bmi1 in cultured cortical neurons conferred robust protection against DNA-damage-induced cell death or mitochondrial poisoning through activation of antioxidant response genes [1]. Taken together, these data suggest that Bmi1 could be the therapeutic target against a diverse range of neuronal diseases. Therefore, we aimed to elucidate Bmi1’s therapeutic potential in an animal model of epilepsy using Bmi1+/- mice.
In our study, Bmi1 expression transiently increased mainly in the CA3 region following both low (200 mg/kg; data not shown) and high (325 mg/kg) doses of pilocarpine, but less prominently in CA1, which is the most vulnerable area in pilocarpine-induced SE. These data are consistent with the observations reported in animal models of kainic acidmicroinjection into the amygdala and may suggest the protective role of Bmi1 against SE [29]. However, there was no difference in neuronal death between wild-type and Bmi1+/-mice in the pilocarpind-induced SE nor in the NMDA-induced neurotoxicity in cultured neurons. However, one should remember that we used heterozygous knockout mice,and the mRNA expression was reduced by about 50%. Although we did not measure protein content, Gu et al. [14] reported that Bmi1 expression in Bmi1+/- mice is reduced by 54% compared to wild type in the hippocampus. These data suggest the possibility that the reduced expression level of Bmi1 in Bmi1+/- mice still provides some protection forCA3 neurons against pilocarpine-induced SE. Further study is needed to clearly determine the protective role of Bmi1 in the animal model of SE.
We also observed that mossy fiber sprouting was significantly increased in Bmi1+/- mice compared to the wild type littermates, but the epileptic behavior was similar between the two groups. The aberrant sprouting of granule cell axons refers to an abnormal and extensive innervation of mossy fibers to the dentate inner molecular layer of the hippocampus and is frequently observed in temporal lobe epilepsy [4]. The role of mossy fiber sprouting in the epileptic brain is controversial. The pro-epileptogenic role of mossy fiber sprouting came from a diverse range of observations. First, the mossy fiber sprouting is frequently observed in patients with temporal lobe epilepsy, as well as in animal models of epilepsy [30,32]. Second, the histological evidence indicates that the sprouted mossy fiber terminals form excitatory synapses with dendritic spines of dentate granule cells [28]. Third, the intensity of mossy fiber sprouting is positively correlated with the degree of cell loss in the CA1 and CA3 regions [26]. On the other hand, there is increasing evidence that mossy fiber sprouting does not cause spontaneous recurrent seizures and is not positively correlated with epileptogenesis. First, spontaneous seizure frequency does not correlate with mossy fiber sprouting [26]. Second, not all epileptic patients develop mossy fiber sprouting [9,23]. Third, a high-dose of rapamycin blocked mossy fiber sprouting to the level of naïve controls without reduction of seizure frequency [15]. Taken together, although mossy fiber sprouting may lead to the epileptogenesis process,they do not appear to be necessary for triggering or maintaining hippocampal hyperexcitability [4]. In addition, the frequency of seizures was reduced in our study; thus, further studies will be needed to elucidate the role of Bmi1 in mossy fiber sprouting in epileptogenesis.
In this study, we observed that Bmi1 hemi-deficiency does not affect pilocarpine-induced SE or neuronal death in the hippocampus. However, Bmi1 hemi-deficiency significantly increased mossy fiber sprouting in the epileptic stage and slightly reduced the percentage and frequency of recurrent seizures. When interpreting these results, it is necessary to be aware that Bmi1 expression was only reduced by about 50% in Bmi1 hemi-deficient mice and, therefore, some protective effects of Bmi1 might persist. Combined, data presented here indicate that Bmi1 is involved in epileptogenesis, although further studies are needed to elucidate its role in epilepsy.
Acknowledgement
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2013168).
The Conflict of Interest Statement
The authors declare that they have no conflicts of interest with the contents of this article.
참고문헌
- Abdouh, M., Chatoo, W., El, H. J., David, J., Ferreira, J. and Bernier, G. 2012. Bmi1 is down-regulated in the aging brain and displays antioxidant and protective activities in neurons. PLoS One 7, e31870. https://doi.org/10.1371/journal.pone.0031870
- Barabino, A., Plamondon, V., Abdouh, M., Chatoo, W., Flamier, A., Hanna, R., Zhou, S., Motoyama, N., Hebert, M., Lavoie, J. and Bernier, G. 2016. Loss of Bmi1 causes anomalies in retinal development and degeneration of cone photoreceptors. Development 143, 1571-1584. https://doi.org/10.1242/dev.125351
- Calao, M., Sekyere, E. O., Cui, H. J., Cheung, B. B., Thomas, W. D., Keating, J., Chen, J. B., Raif, A., Jankowski, K., Davies, N. P., Bekkum, M. V., Chen, B., Tan, O., Ellis, T., Norris, M. D., Haber, M., Kim, E. S., Shohet, J. M., Trahair, T. N., Liu, T., Wainwright, B. J., Ding, H. F. and Marshall, G. M. 2013. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation. Oncogene 32, 3616-3626. https://doi.org/10.1038/onc.2012.368
- Cavarsan, C. F., Malheiros, J., Hamani, C., Najm, I. and Covolan, L. 2018. Is mossy fiber sprouting a potential therapeutic target for epilepsy? Front Neurol. 9, 1023. https://doi.org/10.3389/fneur.2018.01023
- Chatoo, W., Abdouh, M., David, J., Champagne, M. P., Ferreira, J., Rodier, F. and Bernier, G. 2009. The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity. J. Neurosci. 29, 529-542. https://doi.org/10.1523/JNEUROSCI.5303-08.2009
- Chen, Z., Brodie, M. J., Liew, D. and Kwan, P. 2018. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 75, 279-286. https://doi.org/10.1001/jamaneurol.2017.3949
- Courel, M., Friesenhahn, L. and Lees, J. A. 2008. E2f6 and Bmi1 cooperate in axial skeletal development. Dev. Dyn. 237, 1232-1242. https://doi.org/10.1002/dvdy.21516
- Davies, J. A. 1995. Mechanisms of action of antiepileptic drugs. Seizure 4, 267-271. https://doi.org/10.1016/S1059-1311(95)80003-4
- de Lanerolle, N. C., Kim, J. H., Williamson, A., Spencer, S. S., Zaveri, H. P., Eid, T. and Spencer, D. D. 2003. A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories. Epilepsia 44, 677-687. https://doi.org/10.1046/j.1528-1157.2003.32701.x
- Dey, A., Xiong, X., Crim, A., Dwivedi, S. K. D., Mustafi, S. B., Mukherjee, P., Cao, L., Sydorenko, N., Baiazitov, R., Moon, Y. C., Dumble, M., Davis, T. and Bhattacharya, R. 2018. Evaluating the mechanism and therapeutic potential of PTC-028, a novel inhibitor of BMI-1 function in ovarian cancer. Mol. Cancer Ther. 17, 39-49. https://doi.org/10.1158/1535-7163.MCT-17-0574
- Ding, X., Lin, Q., Ensenat-Waser, R., Rose-John, S. and Zenke, M. 2012. Polycomb group protein Bmi1 promotes hematopoietic cell development from embryonic stem cells. Stem Cells Dev. 21, 121-132. https://doi.org/10.1089/scd.2010.0539
- El Hajjar, J., Chatoo, W., Hanna, R., Nkanza, P., Tétreault, N., Tse, Y. C., Wong, T. P., Abdouh, M. and Bernier, G. 2019. Heterochromatic genome instability and neurodegeneration sharing similarities with Alzheimer's disease in old Bmi1+/- mice. Sci. Rep. 9, 594. https://doi.org/10.1038/s41598-018-37444-3
- Ginjala, V., Nacerddine, K., Kulkarni, A., Oza, J., Hill, S. J., Yao, M., Citterio, E., van Lohuizen, M. and Ganesan, S. 2011. Bmi1 is recruited to DNA breaks and contributes to DNA damage-induced H2A ubiquitination and repair. Mol. Cell Biol. 31, 1972-1982. https://doi.org/10.1128/MCB.00981-10
- Gu, M., Shen, L., Bai, L., Gao, J., Marshall, C., Wu, T., Ding, J., Miao, D. and Xiao, M. 2014. Heterozygous knockout of the Bmi-1 gene causes an early onset of phenotypes associated with brain aging. Age (Dordr) 36, 129-139. https://doi.org/10.1007/s11357-013-9552-9
- Heng, K., Haney, M. M. and Buckmaster, P. S. 2013. Highdose rapamycin blocks mossy fiber sprouting but not seizures in a mouse model of temporal lobe epilepsy. Epilepsia 54, 1535-1541. https://doi.org/10.1111/epi.12246
- Janaki Ramaiah, M. and Vaishnave, S. 2018. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer. Gene 678, 302-311. https://doi.org/10.1016/j.gene.2018.08.022
- Katzung, B. G. 2018. Basic & Clinical Pharmacology, pp. 409, 14th ed., McGraw-Hill: 1325 Avenue of the Americas New York, NY, USA.
- Lee, K. E., Cho, K. O., Choi, Y. S. and Kim, S. Y. 2016. The neuroprotective mechanism of ampicillin in a mouse model of transient forebrain ischemia. Kor. J. Physiol. Pharmacol. 20, 185-192. https://doi.org/10.4196/kjpp.2016.20.2.185
- Leung, C., Lingbeek, M., Shakhova, O., Liu, J., Tanger, E., Saremaslani, P., Van Lohuizen, M. and Marino, S. 2004. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428, 337-341. https://doi.org/10.1038/nature02385
- Li, A., Choi, Y. S., Dziema, H., Cao, R., Cho, H. Y., Jung, Y. J. and Obretan, K. 2010. Proteomic profiling of the epileptic dentate gyrus. Brain Pathol. 20, 1077-1089. https://doi.org/10.1111/j.1750-3639.2010.00414.x
- Li, J., Vangundy, Z. and Poi, M. 2020. PTC209, a specific inhibitor of BMI1, promotes cell cycle arrest and apoptosis in cervical cancer cell lines. Anticancer Res. 40, 133-141. https://doi.org/10.21873/anticanres.13934
- Liu. J., Cao, L., Chen, J., Song, S., Lee, I. H., Quijano, C., Liu, H., Keyvanfar, K., Chen, H., Cao, L. Y., Ahn, B. H., Kumar, N. G., Rovira, I. I., Xu, X. L., Van Lohuizen, M., Motoyama, N., Deng, C. X. and Finkel, T. 2009. Bmi1 regulates mitochondrial function and the DNA damage response pathway. Nature 459, 387-392. https://doi.org/10.1038/nature08040
- Masukawa, L. M., Uruno, K., Sperling, M., O'Connor, M. J. and Burdette, L. J. 1992. The functional relationship between antidromically evoked field responses of the dentate gyrus and mossy fiber reorganization in temporal lobe epileptic patients. Brain Res. 579, 119-127. https://doi.org/10.1016/0006-8993(92)90750-4
- Park, I. K., Morrison, S. J. and Clarke, M. F. 2004. Bmi1, stem cells, and senescence regulation. J. Clin. Invest. 113, 175-179. https://doi.org/10.1172/jci20800
- Pathan, S. A., Jain, G. K., Akhter, S., Vohora, D., Ahmad, F. J. and Khar, R. K. 2010. Insights into the novel three 'D's of epilepsy treatment: drugs, delivery systems and devices. Drug Discov. Today 15, 717-732. https://doi.org/10.1016/j.drudis.2010.06.014
- Polli, R. S., Malheirosm, J. M., Dos Santos, R., Hamani, C., Longo, B. M., Tannús, A., Mello, L. E. and Covolan, L. 2014. Changes in hippocampal volume are correlated with cell loss but not with seizure frequency in two chronic models of temporal lobe epilepsy. Front Neurol. 5, 111.
- Racine, R. J. 1972. Modification of seizure activity by electrical stimulation. II. motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281-294. https://doi.org/10.1016/0013-4694(72)90177-0
- Represa, A., Jorquera, I., Le Gal La Salle, G. and Ben-Ari, Y. 1993. Epilepsy induced collateral sprouting of hippocampal mossy fibers: does it induce the development of ectopic synapses with granule cell dendrites? Hippocampus 3, 257-268.
- Reynolds, J. P., Miller-Delaney, S. F., Jimenez-Mateos, E. M., Sano, T., McKiernan, R. C., Simon, R. P. and Henshall, D. C. 2015. Transcriptional response of polycomb group genes to status epilepticus in mice is modified by prior exposure to epileptic preconditioning. Front Neurol. 6, 46. https://doi.org/10.3389/fneur.2015.00046
- Schmeiser, B., Zentner, J., Prinz, M., Brandt, A. and Freiman, T. M. 2017. Extent of mossy fiber sprouting in patients with mesiotemporal lobe epilepsy correlates with neuronal cell loss and granule cell dispersion. Epilepsy Res. 129, 51-58. https://doi.org/10.1016/j.eplepsyres.2016.11.011
- Schmidt, D. 2009. Drug treatment of epilepsy: options and limitations. Epilepsy Behav. 15, 56-65. https://doi.org/10.1016/j.yebeh.2009.02.030
- Shibley, H. and Smith, B. N. 2002. Pilocarpine-induced status epilepticus results in mossy fiber sprouting and spontaneous seizures in C57BL/6 and CD-1 mice. Epilepsy Res. 49, 109-120. https://doi.org/10.1016/S0920-1211(02)00012-8
- Siddique, H. R. and Saleem, M. 2012. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences. Stem Cells 30, 372-378. https://doi.org/10.1002/stem.1035
- Stapels, M., Piper, C., Yang, T., Li, M., Stowell, C., Xiong, Z. G., Saugstad, J., Simon, R. P., Geromanos, S., Langridge, J., Lan, J. Q. and Zhou, A. 2010. Polycomb group proteins as epigenetic mediators of neuroprotection in ischemictolerance. Sci. Signal. 3, 10.
- Trahair, T. N., Liu, T., Wainwright, B. J., Ding, H. F. andMarshall, G. M. 2013. Direct effects of Bmi1 on p53 proteinstability inactivates oncoprotein stress responses in embryonalcancer precursor cells at tumor initiation. Oncogene 32,3616-3626. https://doi.org/10.1038/onc.2012.368
- Valk-Lingbeek, M. E., Bruggeman, S. W. and van Lohuizen,M. 2004. Stem cells and cancer; the polycomb connection.Cell 118, 409-418. https://doi.org/10.1016/j.cell.2004.08.005
- Wang, M. C., Li, C. L., Cui, J., Jiao, M., Wu, T., Jing, L.and Nan, K. J. 2015. BMI-1, a promising therapeutic targetfor human cancer. Oncol. Lett. 10, 583-588. https://doi.org/10.3892/ol.2015.3361
- Xu, X., Wang, Z., Liu, N., Zhang, P., Liu, H., Qi, J. andTu, Y. 2018. The mechanism of BMI1 in regulating cancerstemness maintenance, metastasis, chemo- and radiationresistance. Cancer Transl. Med. 4, 59-63. https://doi.org/10.4103/ctm.ctm_7_18